Asia · Regional markets · Business Standard

Sebi warns Dabur India over delay in disclosing USFDA warning letter

Published by Business Standard · India 6 h ago

The market regulator has cautioned Dabur India over delayed disclosure of a USFDA warning letter, saying repeated violations could attract enforcement action under Sebi rules.

Read the full article on Business Standard Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.business-standard.com)

Also worth reading

The Straits Times Business

Sebi warns Dabur India over delay in disclosing USFDA warning letter

Share

Also worth reading

How the law prevents ‘ineligible buyers’ from investing in properties

Quick Mart IPO Draws Strong Demand as Kenyan Listings Pick Up

AI trade rout: Are global financial markets showing signs of a bigger crisis?

Multinational companies deepen investment and localization efforts

Bitcoin selloff eases as investors explore cautious recovery

Israel’s Iran war leaves Netanyahu estranged from Washington